Patents by Inventor Arnaud Fournial

Arnaud Fournial has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10758473
    Abstract: According to the present invention, an extract is obtained from the Globularia genus is obtained from a plant of the genus Globularia and is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is Globularia cordifolia and the extract is obtained by in vitro plant culture. The extract can be used for preventing and/or treating skin ageing by stimulating the reactions of detoxification and cellular regeneration through a hormetic type response, for improving the transparency and radiance of complexion, for preventing or treating sensitive and reactive skins, for preventing or treating rednesses, for preventing protein glycation, for increasing and/or maintaining the number of dermal stem cells, for increasing and/or maintaining the dermal macromolecules, in particular collagen and elastin, for increasing the volume of the dermis, for preventing and/or treating fines lines and wrinkles, for firming skin, for preventing hair loss and/or stimulating hair regrowth.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: September 1, 2020
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Caroline Le Moigne
  • Patent number: 10159636
    Abstract: The present invention relates to the field of cosmetic and dermopharmaceutical compositions. It concerns oligomer compounds of D-glucuronic acid or D-glucuronate with a ? (1-4) sequence (or oligoglucuronans) containing a degree of acetylation specifically between 8.7±0.5 and 9.2±0.5% by weight of O—CO—CH3 group compared to the weight of glucuronic acid and with a degree of polymerisation (DP) of 18-19±2. The oligomer compounds according to the present invention are intended to stimulate the elasticity of the dermis and epidermis although they also act to increase dermo-epidermal cohesion in order to combat skin ageing, lines, wrinkles, visible and/or tactile skin discontinuities, loss of firmness, elasticity and tone and to combat skin tissue deformability. The invention also concerns a cosmetic composition containing at least one compound as recited according to the present invention.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: December 25, 2018
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Caroline Le Moigne, Philippe Mondon
  • Publication number: 20180318204
    Abstract: The extract of plant origin is characterized in that it is obtained from a plant of the genus Globularia, preferably the species Globularia Cordifolia. The extract according to the invention can be obtained by in vitro plant culture of undifferentiated cells. It can be used as an active agent in a composition for preventing and/or treating skin aging by stimulating detoxification reactions and cellular regeneration thanks to a hormetic type response. With such a composition, improvement of the visual appearance of the skin, radiance and transparency of complexion is obtained for example.
    Type: Application
    Filed: March 23, 2018
    Publication date: November 8, 2018
    Applicant: Sederma
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Caroline Le Moigne
  • Patent number: 9925135
    Abstract: According to the present invention the extract of plant origin of the Globularia genus is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is Globularia cordifolia and the extract is obtained by in vitro plant culture. The extract can be used in particular for preventing and/or treating skin ageing by stimulating the 10 reactions of detoxification and cellular regeneration through a hormetic type response, for improving the transparency and radiance of complexion, for preventing or treating sensitive and reactive skins, for preventing or treating rednesses, for preventing protein glycation, for increasing and/or maintaining the number of dermal stem cells, for increasing and/or maintaining the dermal macromolecules, in particular collagen and elastin, for increasing the volume of the dermis, for 15 preventing and/or treating fines lines and wrinkles, for firming skin, for preventing hair loss and/or stimulating hair regrowth.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: March 27, 2018
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Caroline Le Moigne
  • Patent number: 9918916
    Abstract: The ingredient comprises a mixture of unsaturated dicarboxylic acids comprising the Z and E isomers of at least one mono-unsaturated dicarboxylic C12-C24 acid, the concentration of the E isomer being of at least 25% by weight based on the total weight of Z and E isomers. The ingredient can be used to form cosmetic or dermatological compositions, in particular for lightening the skin, improving the clarity and unification of the skin complexion.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: March 20, 2018
    Assignees: SEDERMA, CRODA INTERNATIONAL PLC
    Inventors: Bas Wels, Arnaud Fournial
  • Patent number: 9737476
    Abstract: The present invention proposes an extract of Albizia Julibrissin for the cosmetic treatment of skin glycation. The extract is preferably obtained from flowers and/or seeds. Application to cosmetic formulations for treating cutaneous fatigue, in particular for improving the radiance of skin and eye contour (under eye bags and dark circles) and for treating the loss of skin suppleness. A preferred composition, particularly adapted for eye contour, comprises the Albizia Julibrissin extract combined with Darutoside that can be extracted from Siegesbeckia Orientalis.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: August 22, 2017
    Assignee: Sederma
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon
  • Publication number: 20170209350
    Abstract: The ingredient comprises a mixture of unsaturated dicarboxylic acids comprising the Z and E isomers of at least one mono-unsaturated dicarboxylic C12-C24 acid, the concentration of the E isomer being of at least 25% by weight based on the total weight of Z and E isomers. The ingredient can be used to form cosmetic or dermatological compositions, in particular for lightening the skin, improving the clarity and unification of the skin complexion.
    Type: Application
    Filed: July 23, 2015
    Publication date: July 27, 2017
    Applicants: SEDERMA, CRODA INTERNATIONAL PLC
    Inventors: BAS WELS, ARNAUD FOURNIAL
  • Patent number: 9126060
    Abstract: Geranylgeranyl-2-propanol compound (GGP) having the following formula I: is proposed for use according to the present invention as a cosmetic active compound for the prevention and treatment of aging of skin and its appendages. The GGP has a protective action against oxidative stress and free radical, on telomeres and on mitochondria and its activity. In particular, GGP can be used for the treatment of wrinkles, fine lines and visible discontinuities of skin, for the treatment pigmentation disorders.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: September 8, 2015
    Assignee: SEDERMA
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
  • Publication number: 20150196475
    Abstract: The present invention relates to the field of cosmetic and dermopharmaceutical compositions. It concerns oligomer compounds of D-glucuronic acid or D-glucuronate with a ? (1-4) sequence (or oligoglucuronans) containing a degree of acetylation specifically between 8.7±0.5 and 9.2±0.5% by weight of O—CO—CH3 group compared to the weight of glucuronic acid and with a degree of polymerisation (DP) of 18-19±2. The oligomer compounds according to the present invention are intended to stimulate the elasticity of the dermis and epidermis although they also act to increase dermo-epidermal cohesion in order to combat skin ageing, lines, wrinkles, visible and/or tactile skin discontinuities, loss of firmness, elasticity and tone and to combat skin tissue deformability. The invention also concerns a cosmetic composition containing at least one compound as recited according to the present invention.
    Type: Application
    Filed: March 23, 2015
    Publication date: July 16, 2015
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Caroline Le Moigne, Philippe Mondon
  • Patent number: 9050477
    Abstract: The present invention related to cosmetic compositions comprising oridonin and new cosmetic uses. Oridonin is used for fighting the signs of cutaneous aging and for slimming. A composition comprising a combination of oridonin and darutigenol or a derivative thereof, in particular darutoside, is disclosed together with the cosmetic use of such composition.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: June 9, 2015
    Assignee: SEDERMA
    Inventors: Arnaud Fournial, Philippe Mondon
  • Publication number: 20150017269
    Abstract: The present invention proposes an extract of Albizia Julibrissin for the cosmetic treatment of skin glycation. The extract is preferably obtained from flowers and/or seeds. Application to cosmetic formulations for treating cutaneous fatigue, in particular for improving the radiance of skin and eye contour (under eye bags and dark circles) and for treating the loss of skin suppleness. A preferred composition, particularly adapted for eye contour, comprises the Albizia Julibrissin extract combined with Darutoside that can be extracted from Siegesbeckia Orientalis.
    Type: Application
    Filed: September 27, 2012
    Publication date: January 15, 2015
    Applicant: SEDERMA
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon
  • Patent number: 8697656
    Abstract: The present invention concerns a peptide of following formula I: R being a side chain having at least one heteroatom selected from sulfur, nitrogen and oxygen in a carbonyl form (C?O); R1 being either H or a lipophilic chain; R2 being either OH or a lipophilic chain. More particularly the present invention concerns a cosmetic composition comprising a peptide as recited above and a physiologically acceptable medium. Results on the activity of the compounds are obtained and on the general state of the skin and its appendages, in particular via the stimulation of extracellular matrix components.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: April 15, 2014
    Assignee: SEDERMA
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
  • Patent number: 8603498
    Abstract: The compound according to the invention has the following developed formula IX: wherein: X=PO(OH)2; SO2(OH); PO(OH)(Xaa)m or SO2(Xaa)m; A=H; OH; NH2 or akyl (1-6C); n=1 to 4; Y=—CO—OR2; —CO—NR3R4; —O—CO—R2; —C?CR2; R2=an alkyl, aryl, aralkyl, acyl, sulfonyl, sugar or alkoxy chain of 1 to 24 carbon atoms, linear, branched or cyclic, with or without substitutions, saturated or not, hydroxylated or not, sulfurated or not; R5=OH, O-alk (1-6C), (Xaa)m, NH2 or NH-alkyl(1-6C); Xaa=peptide of m aminoacids Xaa with m from 1 to 10; The compound is preferably phosphated, obtained from malic acid and having the following developed formula: A cosmetic composition comprising the compound of the present invention can improve the general condition of the skin, for example hydration, lightening and mechanical properties.
    Type: Grant
    Filed: January 17, 2011
    Date of Patent: December 10, 2013
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
  • Publication number: 20130309332
    Abstract: According to the present invention the extract of plant origin of the Globularia genus is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is Globularia cordifolia and the extract is obtained by in vitro plant culture. The extract can be used in particular for preventing and/or treating skin ageing by stimulating the 10 reactions of detoxification and cellular regeneration through a hormetic type response, for improving the transparency and radiance of complexion, for preventing or treating sensitive and reactive skins, for preventing or treating rednesses, for preventing protein glycation, for increasing and/or maintaining the number of dermal stem cells, for increasing and/or maintaining the dermal macromolecules, in particular collagen and elastin, for increasing the volume of the dermis, for 15 preventing and/or treating fines lines and wrinkles, for firming skin, for preventing hair loss and/or stimulating hair regrowth.
    Type: Application
    Filed: January 30, 2012
    Publication date: November 21, 2013
    Applicant: SEDERMA, S.A.S.
    Inventors: Arnaud Fournial, Claire-Marie Grizaud, Philippe Mondon, Caroline Le Moigne
  • Publication number: 20130058878
    Abstract: Geranylgeranyl-2-propanol compound (GGP) having the following formula (I) is proposed for use according to the present invention as a cosmetic active compound for the prevention and treatment of aging of skin and its appendages. The GGP has a protective action against oxidative stress and free radical, on telomeres and on mitochondria and its activity. In particular, GGP can be used for the treatment of wrinkles, fine lines and visible discontinuities of skin, for the treatment pigmentation disorders.
    Type: Application
    Filed: April 7, 2011
    Publication date: March 7, 2013
    Applicant: SEDERMA
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
  • Patent number: 8388939
    Abstract: The subject matter of the present invention is a cosmetic or dermopharmaceutic composition comprising a combination of homarine and erythritol as well as a non-therapeutic treatment method of the skin to improve cutaneous hydration, to prevent and/or treat cutaneous dryness signs, to restore and/or protect the cutaneous barrier function, to protect cells of the skin and/or of the scalp from osmotic shocks, for example from UV induced osmotic shocks.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: March 5, 2013
    Assignee: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Claire Mas-Chamberlin, Philippe Mondon, Olivier Peschard
  • Publication number: 20130004439
    Abstract: The compound according to the invention has the following developed formula IX: wherein: X=PO(OH)2; SO2(OH); PO(OH)(Xaa)m or SO2(Xaa)m; A=H; OH; NH2 or akyl (1-6C); n=1 to 4; Y=—CO—OR2; —CO—NR3R4; —O—CO—R2; —C?CR2; R2=an alkyl, aryl, aralkyl, acyl, sulfonyl, sugar or alkoxy chain of 1 to 24 carbon atoms, linear, branched or cyclic, with or without substitutions, saturated or not, hydroxylated or not, sulfurated or not; R5=OH, O-alk (1-6C), (Xaa)m, NH2 or NH-alkyl(1-6C); Xaa=peptide of m aminoacids Xaa with m from 1 to 10; The compound is preferably phosphated, obtained from malic acid and having the following developed formula: A cosmetic composition comprising the compound of the present invention can improve the general condition of the skin, for example hydration, lightening and mechanical properties.
    Type: Application
    Filed: January 17, 2011
    Publication date: January 3, 2013
    Applicant: Sederma, S.A.S.
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
  • Publication number: 20120076842
    Abstract: The present invention concerns a new cosmetic use of Tyr-Arg dipeptide to stimulate molecules of the extracellular matrix in order to prevent and treat cutaneaous sagging, in particular due to natural gravity. The invention is useful in the preparation of tightening, finning, contouring, and lifting cosmetic products.
    Type: Application
    Filed: May 25, 2010
    Publication date: March 29, 2012
    Applicant: SEDERMA
    Inventors: Arnaud Fournial, Philippe Mondon
  • Publication number: 20120028916
    Abstract: The present invention related to cosmetic compositions comprising oridonin and new cosmetic uses. Oridonin is used for fighting the signs of cutaneous aging and for slimming. A composition comprising a combination of oridonin and darutigenol or a derivative thereof, in particular darutoside, is disclosed together with the cosmetic use of such composition.
    Type: Application
    Filed: April 15, 2010
    Publication date: February 2, 2012
    Applicant: SEDERMA
    Inventors: Arnaud Fournial, Philippe Mondon
  • Publication number: 20120014887
    Abstract: The present invention concerns a peptide of following formula I: R being a side chain having at least one heteroatom selected from sulfur, nitrogen and oxygen in a carbonyl form (C?O); R1 being either H or a lipophilic chain; R2 being either OH or a lipophilic chain. More particularly the present invention concerns a cosmetic composition comprising a peptide as recited above and a physiologically acceptable medium. Results on the activity of the compounds are obtained and on the general state of the skin and its appendages, in particular via the stimulation of extracellular matrix components.
    Type: Application
    Filed: January 15, 2010
    Publication date: January 19, 2012
    Applicant: SEDERMA
    Inventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard